Researcher.Life Logo

Acta Diabetologica : Impact Factor & More

eISSN: 1432-5233pISSN: 0940-5429

Key Metrics

CiteScore
6.7
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Endocrinology
SNIP
1.14
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Acta Diabetologica

Acta Diabetologica Journal Specifications

Overview
Publisher SPRINGER-VERLAG ITALIA SRL
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1964
Website URLVisit website
View less

Planning to publish in Acta Diabetologica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Acta Diabetologica

Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study Group.
  • 18 May 2026
  • Acta diabetologica
GLP-1 RA semaglutide for alcohol use disorder: a potential multi-target therapy.
  • 16 May 2026
  • Acta diabetologica
Switching patterns of GLP-1 receptor agonists from 2018 to 2025 in the largest private healthcare network in Poland.
  • 16 May 2026
  • Acta diabetologica
The effect of GLP-1 receptor agonists on osteoarthritis risk in individuals with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized controlled trials.
  • 8 May 2026
  • Acta diabetologica
Impact of controlled type 2 diabetes on muscle-tendon mechanics.
  • 6 May 2026
  • Acta diabetologica
Clarifications on the report of maternally inherited diabetes and deafness managed with an advanced hybrid closed loop system.
  • 6 May 2026
  • Acta diabetologica
Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study Group.
  • 18 May 2026
  • Acta diabetologica
GLP-1 RA semaglutide for alcohol use disorder: a potential multi-target therapy.
  • 16 May 2026
  • Acta diabetologica
Switching patterns of GLP-1 receptor agonists from 2018 to 2025 in the largest private healthcare network in Poland.
  • 16 May 2026
  • Acta diabetologica
The effect of GLP-1 receptor agonists on osteoarthritis risk in individuals with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized controlled trials.
  • 8 May 2026
  • Acta diabetologica
Impact of controlled type 2 diabetes on muscle-tendon mechanics.
  • 6 May 2026
  • Acta diabetologica
Clarifications on the report of maternally inherited diabetes and deafness managed with an advanced hybrid closed loop system.
  • 6 May 2026
  • Acta diabetologica

FAQs on Acta Diabetologica